Medtronic Drug Eluting Coronary Stents

SUNY Upstate Medical University intends to purchase Medtronic Drug Eluting Coronary Stents and Related Products from a contract awarded by Premier pursuant to its authority under section 163 (3) (vi), which authorizes the purchases of commodities from a consortium or comparable entity in lieu of using a centralized contract and without a formal competitive process when justified by price. Vendors who sell equivalent Medtronic Drug Eluting Coronary Stents and Related Products may, if interested, contact Honey-Beth Nelson todiscuss the procurement. Equivalency must be demonstrated by meeting the clinical performance of the Medtronic Drug Eluting Coronary Stents and Related Products. If offering a clinical equivalent, the vendor must provide free supporting clinical documentation, and equipment for examination, demonstration, and trial. Vendor must be authorized to sell Medtronic Drug Eluting Coronary Stents as listed on the Premier contract or approved equivalent. This procurement is subject to NYS Finance Law §139 j&k, AKA the Lobbying Law. Therefore, vendors are cautioned that the only permissible contact for this Law. Therefore, vendors are cautioned that the only permissible contact for this procurement is the individual listed below. Contacting any other individuals at Upstate in connection with this advertisement may constitute a violation of New York State Finance Law. Failure to comply with this requirement can range from no contract award to debarment from sales to any NYS Agency. Successful contractor shall be required to submit valid and current NYS Workman’s Compensation and Disability Forms. Anyone who can provide the above describe product or clinical equivalent is invited to contact SUNY Upstate Medical University’s Hospital Purchasing Department as shown below. Business enterprises awarded an identical or substantially similar procurement contract within the past five years: None